Whilst BOTOX™ is traditionally used to smooth out laughter lines and fine wrinkles, it seems that many people will soon seek BOTOX™ for an alternative treatment – to help prevent cold sores.
The infection, caused by the herpes simplex virus around the mouth, can remain dormant in the nerve tissues of the face and re-occur at the most inconvenient times. For some people the cold sore virus can surface on an almost weekly basis, usually in the same area.
Now, researchers at the Chicago Centre for Facial Plastic Surgery are testing BOTOX™ against the persistent and irritating virus.
The study will give BOTOX™ injections, which paralyse muscles in the face, to men and women who suffer repeated cold sore outbreaks, every three months for a year.
It is believed the BOTOX™ will stop the virus from reactivating by blocking the nerve where it lies dormant.
Further research into the affects of BOTOX™ has revealed it can also be used to treat migraines by blocking the pain signals of these intense headaches.
Patients looking into BOTOX™ treatments should look no further than The Hospital Group, one of the country’s leading cosmetic surgery providers.
David Ross, Chief Executive of The Hospital Group, said: “BOTOX™ is a great treatment that can abolish laughter lines and any unwanted wrinkles on the face and it’s really interesting to know that the procedure can actually help to rid uncomfortable cold sores that often re-occur and cause the sufferer embarrassment and discomfort.
“Many people feel self conscious about their crows feet or lines around their mouth and BOTOX™ can give the patient a much fresher appearance as well as restoring their confidence and happiness.
“It is important that consumers only seek treatments for BOTOX™ from recognised and trained medical aesthetic healthcare practitioners.
“The Hospital Group carries out all its procedures in state-of-the-art facilities and our expert’s are always on hand to give advice. People can be assured of a safe, dependable solution to their wrinkles.”
Cosmetic surgery news : 30 November 2010